Neuropathological hallmarks of fetal hydrocephalus linked to CCDC88C pathogenic variants.

Autosomal recessive inheritance CCDC88C pathogenic variants Choroid plexus hydrops Diaphragmatic defect Foetal hydrocephalus Multiple ependymal malformations Neural tube defect Neuropathology Planar cell polarity Renal agenesis

Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
06 06 2021
Historique:
received: 26 03 2021
accepted: 29 05 2021
entrez: 7 6 2021
pubmed: 8 6 2021
medline: 15 12 2021
Statut: epublish

Résumé

The prevalence of congenital hydrocephalus has been estimated at 1.1 per 1000 infants when including cases diagnosed before 1 year of age after exclusion of neural tube defects. Classification criteria are based either on CSF dynamics, pathophysiological mechanisms or associated lesions. Whereas inherited syndromic hydrocephalus has been associated with more than 100 disease-causing genes, only four genes are currently known to be linked to congenital hydrocephalus either isolated or as a major clinical feature: L1CAM, AP1S2, MPDZ and CCDC88C. In the past 10 years, pathogenic variants in CCDC88C have been documented but the neuropathology remains virtually unknown. We report the neuropathology of two foetuses from one family harbouring two novel compound heterozygous pathogenic variants in the CCDC88C gene: a maternally inherited indel in exon 22, c.3807_3809delinsACCT;p.(Gly1270Profs*53) and a paternally inherited deletion of exon 23, c.3967-?_c.4112-?;p.(Leu1323Argfs*10). Medical termination of pregnancy was performed at 18 and 23 weeks of gestation for severe bilateral ventriculomegaly. In both fetuses, brain lesions consisted of multifocal atresia-forking along the aqueduct of Sylvius and the central canal of the medulla, periventricular neuronal heterotopias and choroid plexus hydrops. The second fetus also presented lumbar myelomeningocele, left diaphragmatic hernia and bilateral renal agenesis. CCDC88C encodes the protein DAPLE which contributes to ependymal cell planar polarity by inhibiting the non-canonical Wnt signaling pathway and interacts with MPDZ and PARD3. Interestingly, heterozygous variants in PARD3 result in neural tube defects by defective tight junction formation and polarization process of the neuroepithelium. Besides, during organ formation Wnt signalling is a prerequisite for planar cell polarity pathway activation, and mutations in planar cell polarity genes lead to heart, lung and kidney malformations. Hence, candidate variants in CCDC88C should be carefully considered whether brain lesions are isolated or associated with malformations suspected to result from disorders of planar cell polarity.

Identifiants

pubmed: 34092257
doi: 10.1186/s40478-021-01207-5
pii: 10.1186/s40478-021-01207-5
pmc: PMC8183048
doi:

Substances chimiques

CCDC88C protein, human 0
Intracellular Signaling Peptides and Proteins 0
Microfilament Proteins 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104

Références

Hum Mutat. 2017 Apr;38(4):378-389
pubmed: 27925688
J Med Genet. 2012 Nov;49(11):708-12
pubmed: 23042809
Mol Biol Cell. 2019 Jul 22;30(16):1900-1910
pubmed: 31268831
Eur J Med Genet. 2018 Apr;61(4):189-196
pubmed: 29225145
EMBO Mol Med. 2019 Jan;11(1):
pubmed: 30518636
Ann Neurol. 2017 Jun;81(6):890-897
pubmed: 28556411
Elife. 2015 Jun 30;4:e07091
pubmed: 26126266
J Med Genet. 2007 Nov;44(11):739-44
pubmed: 17617514
Cell Rep. 2017 Jul 25;20(4):960-972
pubmed: 28746879
Acta Neuropathol. 2013 Sep;126(3):427-42
pubmed: 23820807
Tissue Barriers. 2014 Mar 19;2:e28426
pubmed: 25045600
Mol Syndromol. 2010 Sep;1(3):99-112
pubmed: 21031079
Mov Disord. 2019 Jan;34(1):142-144
pubmed: 30398676
Nat Med. 2020 Nov;26(11):1754-1765
pubmed: 33077954
J Med Genet. 2014 Sep;51(9):590-5
pubmed: 25062847
Acta Neuropathol Commun. 2017 May 1;5(1):36
pubmed: 28460636
Curr Opin Cell Biol. 2018 Dec;55:96-103
pubmed: 30015152
Genomics. 1999 Jul 1;59(1):102-4
pubmed: 10395806
Am J Med Genet A. 2018 Mar;176(3):676-681
pubmed: 29341397
iScience. 2020 Feb 21;23(2):100859
pubmed: 32058970

Auteurs

Florent Marguet (F)

UNIROUEN, INSERM U1245, Rouen University Hospital, Department of Pathology, Normandie Univ, 76000, Rouen, France.

Myriam Vezain (M)

UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France.

Pascale Marcorelles (P)

UBO EA 4685 LIEN and Brest University Hospital, Pathology Department, Brest Univ, 29609, Brest, France.

Séverine Audebert-Bellanger (S)

Department of Genetics, Brest University Hospital, 29200, Brest, France.

Kévin Cassinari (K)

UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France.

Nathalie Drouot (N)

UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France.

Pascal Chambon (P)

UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France.

Bruno J Gonzalez (BJ)

UNIROUEN, INSERM U1245, Normandy Centre for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France.

Arie Horowitz (A)

UNIROUEN, INSERM U1245, Normandy Centre for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France.

Annie Laquerriere (A)

UNIROUEN, INSERM U1245, Rouen University Hospital, Department of Pathology, Normandie Univ, 76000, Rouen, France. annie.laquerriere@chu-rouen.fr.
Pathology Laboratory, Pavillon Jacques Delarue, CHR, 1 rue de Germont, 76031, Rouen Cedex, France. annie.laquerriere@chu-rouen.fr.

Pascale Saugier-Veber (P)

UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH